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ABSTRACT
Objective This study aims to investigate the accuracy
and validity of the Australasian Triage Scale (ATS) as a
tool to identify and manage in a timely manner the
deteriorating patient with severe sepsis.
Methods This was a prospective observational study
conducted in ﬁve sites of adult patients. Keywords and
physiological vital signs data from triage documentation
were analysed for the ‘identiﬁed’ status compared with
conﬁrmed diagnosis of severe sepsis after admission to
the intensive care unit. The primary outcome is the
accuracy and validity of the ATS Triage scale categories
to identify a prespeciﬁed severe sepsis population at
triage. Secondary outcome measures included time
compliance, antimicrobial administration and mortality
prediction. Statistical analysis included parameters of
diagnostic performance. Adjusted multivariate logistic
regression analysis was applied to mortality prediction.
Results Of 1022 patients meeting the criteria for
severe sepsis, 995 were triaged through the emergency
department, 164 with shock. Only 53% (n=534) were
identiﬁed at triage. The overall sensitivity of the ATS to
identify severe sepsis was 71%. ATS 3 was the most
accurate (likelihood ratio positive, 2.45, positive
predictive value 0.73) and ATS 2 the most valid (area
under the curve 0.567) category. Identiﬁed cases were
more likely to survive (OR 0.81, 95% CI 0.697 to 0.94,
p<0.007). The strongest bias-adjusted predictors of
mortality were circulatory compromise variable (1.78,
95% CI 1.34 to 1.41, p<0.001), lactate >4 (OR 1.63,
95% CI 1.10 to 2.89, p<0.001) and ATS 1 category
(OR 1.55, 95% CI 1.09 to 2.35, p<0.005).
Conclusions The ATS and its categories is a sensitive
and moderately accurate and valid tool for identifying
severe sepsis in a predetermined group, but lacks clinical
efﬁcacy and safety without further education or quality
improvement strategies targeted to the identiﬁcation of
severe sepsis.
INTRODUCTION
Severe sepsis is deﬁned as the systemic inﬂammatory
response (SIRS) to infection plus sepsis-induced
organ dysfunction or tissue hypo-perfusion.1 It
remains a major cause of morbidity and mortality
globally with a 20%–30% mortality rate.2 The iden-
tiﬁcation of severe sepsis relies on the presenting
pattern of physiological vital signs, symptoms and
history related to infection, SIRS response and
organ failure.3 Fever is often the ﬁrst presenting
abnormality in approximately 40% of patients.2 4 5
Pneumonia infections are the most common with
genitourinary infections the most common
presentation in older persons. The absence of fever
and presence of sepsis-induced hypothermia are
more likely in patients at the extremes of age, debili-
tated patients, those with chronic alcohol, liver and
renal disease.5 6 Withdrawal and agitation can be
subtle and may be the sole presentations of sepsis in
the elderly.2 Patients with severe sepsis represent the
population at the greatest risk of unchecked deteri-
oration in our healthcare systems.4–6 The challenges
in reliably identifying severe sepsis on clinical pres-
entation remain the greatest barrier to implementing
any guidelines,7 institutional protocols8 9 or toolk-
its10 developed to reduce mortality.
Triage to the emergency department (ED) is the
most critical time in the identiﬁcation of evolving
severe sepsis and is the ﬁrst part of a differential
diagnosis. Therefore, it is essential that any tool or
scale designed to assist allows for a rapid and
reliable identiﬁcation. Then, early resuscitation
interventions can be implemented, including anti-
microbial therapy within the ﬁrst hour.11 12
Key messages
What is already known on this subject
▸ Patients with severe sepsis represent the
population at the greatest risk of unchecked
deterioration in our healthcare systems.
▸ Triage to the emergency department is the
most critical time in the identiﬁcation of
evolving severe sepsis.
▸ Poor identiﬁcation impacts on patient survival
and the ability to implement appropriate
resuscitation measures.
What this study adds
▸ The Australasian Triage Scale (ATS) is
comprised of descriptors that match the
consensus criteria for severe sepsis.
▸ The accuracy and validity of the ATS categories
to identify severe sepsis were moderate in a
predetermined cohort of severe sepsis patients.
▸ There was moderate agreement between those
identiﬁed at triage in the emergency
department and conﬁrmed diagnosis of severe
sepsis in the intensive care unit.
▸ Circulatory compromise as described in ATS 2
and elevated lactate were the strongest
predictors of inhospital mortality.
▸ Patients who were identiﬁed with severe sepsis
at triage were more likely to survive.
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The Australasian Triage Scale (ATS) consists of ﬁve tiers that
link patient history and physiological vital signs and symptoms
to clinical urgency and the maximum time that patients should
wait.13 The most urgent clinical feature determines the ATS cat-
egory, with consideration of the presenting history, features, age
and comorbidities. ATS category 1 requires immediate attention
and ATS category 2 has a maximum waiting time of 10 min.
The clinical descriptors provide a guide to each category and
are similar to the physiological vital signs and symptoms
included in the consensus deﬁnition of severe sepsis1 and may
assist in its identiﬁcation at triage as described in tables 1 and 2.
The triage characteristics of patients with infection were
described by Fry et al,14 where less urgent triage codes were
allocated to patients with infection compared with patients with
non-infective conditions. While allocating a lower urgency code
may have been clinically reasonable, there was evidence to
suggest that sepsis mortality rate was impacted due to poor
identiﬁcation.
In 2010, Tromp et al15 reported that 65% of ED patients
were accurately identiﬁed and diagnosed by the triage nurses
compared with conﬁrmed discharge data. This was after an edu-
cation programme in phase II of the study. Yet, there was no
triage tool or scale reported or validated in the study.
Many studies examining compliance with the severe sepsis
guidelines, bundles or protocols in the ED report difﬁculties in
the identiﬁcation of severe sepsis.16–18 Still, there was no refer-
ence to which triage tools or scales were used to identify the
condition. Accordingly, the validation of an identiﬁcation system
that would remain accurate when applied to patients with severe
sepsis at the time of ED presentation is of high priority for both
bedside clinical care and clinical research trials.
Therefore, the aim of this study was to determine the accur-
acy and validity of the ATS to appropriately identify and
manage in a timely manner the deteriorating patient with severe
sepsis including the administration of antimicrobial therapy.
METHODS
This study was a secondary analysis of a larger prospective
observational study conducted in ﬁve sites investigating compli-
ance with the sepsis guidelines. All adult sepsis patients triaged
in the ED and consecutively admitted to the intensive care unit
(ICU) of a participating site and meeting the consensus criteria1
for severe sepsis on ICU admission were included. Less than
24 h stay in the ICU, paediatric cases and readmissions were
excluded. Patients were followed up until hospital discharge or
death for inhospital mortality data.
Table 1 The ATS categories, MWT and ATS clinical descriptors that match descriptors of the consensus definition of severe sepsis
ATS category and MWT ATS clinical descriptors that match the consensus definition descriptors of severe sepsis
ATS 1:
immediately life-threatening—
MWT nil
requires immediate attention
Cardiac arrest
Respiratory arrest
Immediate risk to airway—impending arrest
RR<10/min
Extreme respiratory distress
BP<80 (adult) or severely shocked child/infant
Unresponsive or responds to pain only (GCS<9)
Ongoing/prolonged seizure
ATS 2:
imminently life-threatening—
MWT 10 min
important time-critical treatment or very severe
pain deteriorating rapidly
Airway risk—severe stridor or drooling with distress
Severe respiratory distress
Circulatory compromise
Clammy or mottled skin, poor perfusion
HR<50 or >150 (adult)
Hypotension with haemodynamic effects
Very severe pain—any cause
BGL<2 mmol/L
Drowsy, decreased responsiveness any cause (GCS<13)
Fever with signs of lethargy
ATS 3:
potentially life-threatening or important time-critical
treatment or severe pain, deterioration noted MWT 30 min
Moderate shortness of breath
SaO2 90%–95%
BGL >16 mmol/L
Seizure (now alert)
Any fever if immunosuppressed, for example, oncology patient, steroid Rx
Persistent vomiting
Dehydration
Moderately severe pain—any cause—requiring analgesia
Chest pain likely non-cardiac and moderate severity
Abdominal pain without high risk features—moderately severe or patient age >65 years
ATS 4:
potentially life-serious or situational urgency
or significant complexity
MWT 60 min
Foreign body aspiration, no respiratory distress
Difficulty swallowing, no respiratory distress
Moderate pain, some risk features
Vomiting or diarrhoea without dehydration
Swollen ‘hot’ joint
Non-specific abdominal pain
ATS 5:
less urgent.
MWT 125 min
Minimal pain with no high risk features
Low-risk history and now asymptomatic
Minor symptoms of existing stable illness
Minor symptoms of low-risk conditions
Minor wounds—small abrasions, minor lacerations (not requiring sutures)
ATS, Australasian Triage Scale; BGL, blood glucose level; BP, systolic BP; MWT, maximum waiting time; Rx, treatment.
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The study was conducted for a full year duration (2010–
2011) to capture seasonal variations. All data were de-identiﬁed.
Ethical approval was obtained from the ﬁve local institutional
research ethics committees and afﬁliated university (106/012).
Informed consent was waived on the basis that this was an epi-
demiological study without clinical intervention, and that
patients managed in the resuscitation room and ICUs are critic-
ally ill and often incapable of fully informed consent. Patient
management was not affected during the study.
Identiﬁcation of severe sepsis at triage classiﬁcation
Triage data were interrogated for patient history, baseline physio-
logical vital signs, symptoms, laboratory data, narrative com-
ments and allocated ATS category. Emergency triage personnel
were blinded to the study and were experienced and consistent in
the use of the ATS. Spontaneously documented keywords and
physiological vital signs data from the triage notes related to the
severe sepsis consensus deﬁnition1 and the International Sepsis
Forum Consensus Conference guidelines on deﬁnitions of infec-
tions provided evidence of the identiﬁcation of the condition.
These were validated by a second researcher author. For
example, the descriptors and/or physiological vital sign data of
the presence of fever, and at least two of purulent sputum,
cough, change in leucocyte count (from referral notes if
applicable) and impaired oxygenation would be classiﬁed as iden-
tiﬁed suspected pneumonia with severe sepsis with the exclusion
of other causes (see table 2 for physiological vital signs, symp-
toms and ATS clinical descriptor category for the stages of sepsis
with typical keywords and physiological vital sign data used for
the classiﬁcation of identiﬁed severe sepsis). Patient cases with
this documentation matching descriptors for ‘fever’ and/or
physiological vital sign data (ie, 38.9°C) and ‘moderate shortness
of breath’ were rated as ‘identiﬁed’ by the use of the ATS scale
during the triage process. Fever or physiological vital sign data
(ie, 38.9°C) documented in isolation would only meet the criteria
for SIRS. As described in table 2, patient cases with documenta-
tion and physiological vital sign data for SIRS (two criteria) plus
suspected infection plus organ dysfunction were categorised as
‘identiﬁed’ with suspected severe sepsis.
Outcome parameters
The primary outcome was the diagnostic accuracy and validity of
the ATS and its categories to appropriately identify severe sepsis
at triage. Secondary outcome measures included appropriate
triage allocation, antimicrobial administration and time compli-
ance. Later, mortality was examined in terms of sepsis identiﬁca-
tion, categories of the ATS, antimicrobial administration and
selected physiological vital sign baseline variables in the ED.
Table 2 Physiological vital signs, symptoms and matching ATS clinical descriptor category for the stages of sepsis with typical keywords used
for identifying severe sepsis
Stages of
sepsis Physiological vital signs and symptoms ATS category
Typical keywords for
identifying* severe sepsis
Suspected
infection
Visual inspection or presenting history and pain:
Cough/purulent sputum
Wound infection
Swollen hot painful joint
Abdominal symptoms
Urinary symptoms
Fever excluding all other causes
ATS 5
ATS 5
ATS 4
ATS 3–4
ATS 3–4
ATS 3–5
Suspected infection—from organ or location
Examples include:
Pneumonia
UTI
Cellulitis
SIRS syndrome Two or more of the following:
Body temperature >38.5°C or <35.0°C (ATS 4) ATS 3 if immunosuppressed or ATS 2
if fever with lethargy
HR >90 bpm
RR >20 breaths/min or arterial CO2 tension <32 mm Hg or need for mechanical
ventilation
White blood cell count >12 000 or <4000/mm3 or immature forms >10%
ATS 2–4
ATS 4–5
ATS 2 3
Not Applicable
unless in referral
Fever or hypothermia
HR elevated
RR elevated
From vital sign data or descriptive
Documentation
Sepsis SIRS syndrome and documented suspicion of infection:
Visual inspection or presenting history and pain
Cough/purulent sputum
Wound
Abdominal symptoms
Urinary symptoms
Fever excluding all other causes
ATS 2–4
Suspected infection—from organ or location
Examples include:
Pneumonia
UTI
Cellulitis
Plus SIRS signs
Severe sepsis Sepsis and at least one sign of organ hypo-perfusion or organ dysfunction:
Kidney—decreased urine output (<0.5 mL/kg for at least 1 h)
Nervous system—abrupt change in mental status
Gut—decreased motility, decreased bowel sounds and anorexia
Blood—thrombocytopenia—bleeding and clotting issues
Heart and circulation—hypotension, tachycardia, mottled skin and capillary refill
>3 s
Lungs—respiratory distress
Skin and muscle—myalgia and mottled skin
ATS 4
ATS 2–3
ATS 3
ATS 3
ATS 2
ATS 2
ATS 2
Keywords that describe the organ dysfunction
Examples include
Nervous system: Acute onset—obtunded,
confused, agitated, disoriented
Circulation: as per signs and symptoms
Keywords
‘? Sepsis’ often used for ‘? severe sepsis’
Septic shock Severe sepsis and one of:
Profound hypovolaemia, hypo-perfusion and hypoxia
Hypovolaemia does not respond to fluid resuscitation
Need for norepinephrine or epinephrine <0.25 μg/kg per min to maintain mean BP
above 60 mm Hg (>80 mm Hg if previous hypertension)
ATS 1–2
ATS 1–2
Not applicable
at triage
Shock or circulatory collapse or similar
*Documentation containing keywords or similar were classified as ‘identified with severe sepsis’.
ATS, Australasian Triage Scale; SIRS, systemic inflammatory response syndrome; UTI, urinary tract infection.
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Statistical analysis
Variables were tabulated and/or reported as mean, SD or
median, IQR, or numbers and proportions as appropriate. No
assumptions were made about missing data which was less than
0.5% due to the prospective method and interrogation of docu-
mented data. Difference testing between groups was performed
using the two-tailed t test, Mann–Whitney U test, χ2 test and
Fisher’s exact test as appropriate. The correlation between two
variables was described with Spearman’s rank correlation coefﬁ-
cients and corresponding p values. The κ statistic was calculated
to measure the level of agreement between the conﬁrmed diag-
nosis of severe sepsis in the ICU and the identiﬁcation of severe
sepsis at triage. We calculated sensitivity, speciﬁcity, positive pre-
dictive value, negative predictive value and probabilities for the
ATS categories performance in identifying our prespeciﬁed
severe sepsis population. Pretest odds were calculated from the
known prevalence of patients in the ATS category. Accuracy was
derived from the likelihood ratio positive (LR+). Diagnostic
validity was related to the receiver operating curve (ROC) and
the area under the curve (AUC) analysis.
For mortality prediction, all data were transformed into
clinically meaningful categories for univariate and multivariate
logistic regression analysis. Variables with p<0.10 from univari-
ate analysis were included in the backward stepwise
logistic regression model that was also corrected for possible
confounders such as age, Sequential Organ Failure Assessment
score (SOFA) and Acute Physiology and Chronic Health
Evaluation II (APACHE II) scores. Terms were removed from
the model if the LR statistic had a signiﬁcance level above 0.10
and terms were re-entered if the LR statistic had a signiﬁcance
level below 0.05. The goodness of ﬁt was assessed by the
Hosmer–Lemeshow test and discrimination by the area
under the ROC using the C-statistic. A two-sided p value of
0.05 was considered statistically signiﬁcant. All analyses were
performed using Intercooled STATA V.11.0 (Stata Corporation,
Texas, USA).
Figure 1 Cohort selection ﬂow diagram.
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RESULTS
There were 7910 admissions to the ﬁve ICUs during the study
period from the ED as described in ﬁgure 1; of these, 2103 were
admissions with an uncomplicated ICU stay of less than 24 h and
185 paediatric admissions; both groups were excluded.
The remaining 5622 ICU admissions were screened for sus-
pected sepsis using consensus criteria1 and 1993 (35%) were iden-
tiﬁed as having a systemic inﬂammation response to a clinically
suspected infection. Of these, 1176 patients were identiﬁed as
having a ﬁrst episode of clinically suspected severe sepsis or septic
shock. Clinical- or microbiological-conﬁrmed infection was
recorded in 1022 (86.9%). A total of 995 cases were triaged
through the ED and of these cases 53% (n=534) were categorised
as ‘identiﬁed’ severe sepsis in the ED during the triage process.
The other 27 were retrieval cases admitted directly to the ICU and
bypassed triage. No other tool or scale was used to identify severe
sepsis (see ﬁgure 1 for the cohort selection ﬂow diagram).
Patient characteristics
As described in table 3, there were 8% more men (552/470),
and the mean age was 57.1 years. The majority of patients had
at least one comorbidity (69%) and more than a third were
obese (35%). The lungs were the most common site of infec-
tion, accounting for 67% of infections, followed by the
abdomen (23%), with multiple cases having more than one
infection site. Blood cultures were obtained in 77% with add-
itional microbiological specimens (eg, sputum, urine) collected
in 55% of patients prior to ICU admission. In all, 72% had
positive microbial isolates: 52% of the positive isolates were
gram-positive, 57% gram-negative and 22% fungal.
In terms of the deﬁning features of SIRS recorded at baseline
at triage (table 3), this cohort featured strongly with 59%
(n=587) having temperature variations either >38 or < 36°C,
76% (n=752) a documented HR >90 bpm, and 32% (n=315)
an RR ≥30 breaths/min. Overall, 51% (n=448) presented with
an acute alteration in mental state. There were 64% (n=641)
who met the criteria for ‘circulatory compromise’, deﬁned in
ATS category 2 as ‘clammy or mottled skin, poor perfusion,
HR<50 or >150 and hypotension with haemodynamic effects.’
Symptomatic organ failure was prevalent with respiratory,
cardiac and renal dysfunction (and others) as evident by the
range of signs and symptoms documented in a large proportion
of cases and conﬁrmed by a mean SOFA score of 6.1 (SD 4.0)
recorded on admission to the ICU.
ATS diagnostic accuracy and validity in identifying
severe sepsis
In terms of identifying severe sepsis, the ATS overall demon-
strated a sensitivity of 71% and a positive predictive value of
0.586 (95% CI 0.554 to 0.599) in a predetermined cohort of
severe sepsis patients. Positive predictive values calculated for
the ATS categories as in table 3 indicated that a positive identiﬁ-
cation made it highly likely that the patient actually did have
severe sepsis. This was especially evident in ATS 2–4.
Identifying accuracy was indicated by the LR+ value greater
than 1 and was most accurate in ATS category 3 (LR+ 2.72,
95% CI 2.50 to 2.97). ATS 1 and 4 were inaccurate for identify-
ing severe sepsis (see table 4 for details). Diagnostic validity was
greatest but moderate in ATS 2 (AUC 0.567, 95% CI 0.528 to
0.574). Overall, the agreement between those identiﬁed at ED
Table 3 Waiting times, baseline physiological data and outcome per ATS triage category of all patients with severe sepsis at triage and ED
Variable ATS1 ATS2 ATS3 ATS4 ATS5 p Value
Cases per ATS category n (%)* 172 (17%) 319 (32%) 258 (26%) 205 (21%) 41 (4%) 0.0516
Recommended MWT per ATS, minutes 1 10 30 60 120 –
Actual waiting time, minutes 5 (±5) 24 (±5) 36 (±15) 68 (±16) 148 (±29) <0.0001
Severe sepsis identified at triage 45 (26) 192 (60) 183 (71) 114 (56) 15 (40) <0.0001
Appropriate empiric antimicrobial prescription† 22 (13) 136 (43) 108 (42) 92 (45) 15 (40) 0.9053
Time to first antimicrobial therapy, minutes 128 (±57) 109 (±63) 136 (±55) 182 (±80) 197 (±78) 0.0011
Lactate >4 mmol, sepsis related 150 (87) 265 (83) 183 (71) 112 (55) 5 (13) <0.0001
BGL >10 mmol 96 (52) 194 (61) 121 (46) 78 (34) 5 (13) <0.0001
Systolic BP, mm Hg 87 (±17) 94 (±17) 105 (±25) 128 (±32) 125 (±35) <0.0031
Circulatory compromise‡ 162 (94) 306 (96) 106 (41) 59 (28) 8 (19) <0.0001
Temperature >38°C 49 (28) 102 (31) 147 (56) 84 (40) 6 (14) <0.0001
Temperature <36°C 63 (36) 149 (47) 35 (13) 2 (0.09) 1 (0.04) <0.0066
GCS 9 (±2) 9 (±3) 11 (±2) 12 (±1) 13 (±1) 0.0384
RR>30 breaths/min 95 (55) 204 (63) 16 (6) – – <0.0001
RR<10 43 (25) 8 (0.02) – – – <0.0001
Nausea/vomiting symptoms 123 (72) 187 (58) 74 (28) 81 (39) 20 (50) 0.0123
Pain score>8 46 (26) 79 (25) 54 (21) 16 (8) – 0.2585
Mean time in ED, hours 1.2 (±0.2) 3 (±0.2) 3.8 (±2.7) 6 (±2.9) 10 (±3.6) <0.0001
Mean APACHE II score (ICU) 26 (±12) 21 (±8) 18 (±9) 11 (±5) 10 (±8) <0.0001
Mean SOFA score (ICU) 9 (±4.9) 8 (±3.6) 5 (±3.3) 3 (±3.1) 3 (±3.8) 0.0103
Hospital mortality n (%) 77 (45) 99 (31) 49 (9) 10 (5) – 0.0024
Values expressed as mean±SD or n (%) of ATS category unless stipulated.
p Value=differences in means and proportions at the 0.5 level.
*Includes all patients with severe sepsis.
†Prescribed and administered in the ED according to hospital guidelines.
‡Circulatory compromise: clammy or mottled skin, poor perfusion, HR<50 or >150, hypotension with haemodynamic effects.
ATS, Australasian Triage Scale; BGL, blood glucose level; ED, emergency department; ICU, measured on admission to the intensive care unit; MWT, minimum waiting time to be seen in
the ED.
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triage and the conﬁrmed diagnosis of severe sepsis in the ICU
was also moderate (κ=0.46, 95% CI 0.430 to 0.496).
Triage allocation, antimicrobial administration and time
compliance
At triage, 174 severe sepsis patients were assigned the ATS 1 cat-
egory and this group were assessed immediately, remained the
shortest time in the ED (mean 1.2 h, SD±2) and had the
highest APACHE II scores on admission to the ICU (mean 26,
SD±2), with the highest inhospital mortality, (n=77, 45%).
Overall, recommended and actual waiting times were correlated
(R=0.763, p<0.001) and compliance varied by 30%.
Overall, less than half the cohort (n=373/995) received
appropriate empiric antimicrobial therapy prescription and
administration in the ED. ATS 2 had the greatest compliance
(136/319) with ATS 1 the lowest compliance (22/172). The
mean time to the ﬁrst empiric antimicrobial therapy administra-
tion ranged from 109 (±63) min for ATS 2, 128 (±57) min for
ATS 1, to 197 (±78) min for ATS 5 (see table 3 for detail).
Sepsis identiﬁcation and predictors of mortality
Patients who were identiﬁed with severe sepsis at triage were
more likely to survive (OR 0.812, 95% CI 0.697 to 0.946,
p<0.007) than those who were not. A positive relationship was
found between the increasingly urgent ATS category and inhos-
pital mortality (χ2 for trend, (4df)=70.62, p <0.001). ATS 1
patients had the highest mortality (OR 1.71, 95% CI 1.21 to
2.41, p=0.001) with ATS 5 patients all surviving. All other ATS
categories were not associated with mortality in the adjusted
model as described in table 5.
The bias adjusted OR using the confounders of age, SOFA
score and APACHE II score found the ‘circulatory compromise’
variable described in ATS 2 as ‘clammy or mottled skin, poor
perfusion, heart rate <50 or >150 bpm and hypotension with
haemodynamic effects,’ to be the strongest predictor of inhospi-
tal mortality (OR 1.78, 95% CI 1.34 to 1.41, p <0.001), as
was lactate>4 category (OR 1.63, 95% CI 1.10 to 2.89,
p<0.001) and the ATS 1 category (OR 1.55, 95% CI 1.09 to
2.35, p=0.005).
DISCUSSION
This study has evaluated the diagnostic accuracy and validity of
the ATS and its categories to assist in the identiﬁcation and
timely management of severe sepsis in a cohort of predeter-
mined severe sepsis patients. Overall, the ATS demonstrated a
sensitivity of 71% in identifying severe sepsis. Accuracy was
greatest in ATS 3 and validity in ATS 2, both of which also con-
tained a greater number of clinical descriptors that matched the
signs and symptoms of severe sepsis, most likely contributing to
the degree of accuracy and validity. Agreement between the con-
ﬁrmed diagnoses of severe sepsis in the ICU and the identiﬁca-
tion of the syndrome at triage was moderately strong.
In reality, the ATS clinical descriptors lack prompts for sus-
pecting infection. In contrast, organ failure hypo-perfusion or
failure descriptors were more prevalent in the ATS clinical
descriptors and therefore act as prompts for that component of
the severe sepsis spectrum making it easier to identify. The
inclusion of more infection related clinical descriptors may assist
in improving the diagnostic accuracy and validity. For example,
abdominal infection: pain, peritonism, respiratory infection:
cough, purulent sputum, shortness of breath, neurological:
altered conscious state, new onset of confusion, neck stiffness,
headache, skin: wound, cellulitis, urine: dysuria, frequency, and
odour. In addition, the inclusion of severe sepsis as a prompt
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and locating it in ATS 2 may improve the timely management of
these patients.
Proportionally, only 53% of patients were identiﬁed accur-
ately and in clinical efﬁcacy and safety terms this was quite low.
In comparison, this was less than in the study by Tromp et al15
who after a targeted education programme identiﬁed 65% of
patients with infection at triage. In this study, the remaining
47% of patients who were not identiﬁed were at greater risk of
deterioration and mortality. Moreover, those identiﬁed at triage
in this study were 18% more likely to survive compared with
those not. This then remains an area for further educational and
quality improvement development strategies.
The Clinical Excellence Commission (CEC) Sepsis Toolkit
(2013)10 states to ‘use a high Australasian Triage Score
(Category 1 or 2) to reﬂect the seriousness of the severe sepsis
patients’ condition and commencement on the sepsis pathway’.
Of this cohort, 49% were allocated to ATS 1–2, with the
remaining 51% being ‘under triaged’ according to the CEC.
The current Surviving Sepsis Campaign Guidelines (SSCG) rec-
ommend administration of broad spectrum empiric intravenous
antimicrobial therapy as soon as possible and within 1 h of diag-
nosing severe sepsis or septic shock.6 Results of trials indicate
that there is a strong correlation between antimicrobial delay
and inhospital mortality.12 19 Only 37% of our study patients
received appropriate initial empiric antimicrobial therapy, and
we contribute this to the time the study was conducted where
the 2008 SSCG were yet to impact on clinical practice. Second,
the growing organism resistance debate may have contributed to
the low rates of prescription. In this study, antimicrobial therapy
was not compliant with the sepsis guideline timeline. The most
urgent ATS 1 category was even less compliant than the ATS 2
category, perhaps more focused on airway, breathing and circula-
tion rather than compliance with the antimicrobial therapy time-
lines. Considering that the ATS is based on time frames, it
underlines the need to have severe sepsis patients allocated in a
higher triage category to enhance the resuscitation care and sur-
veillance required by patients at risk of deterioration.
Inadvertently, what may have been validated in this study was
the ability and accuracy of the ATS to identify hypo-perfusion.
Hypo-perfusion is prevalent in severe sepsis patients and is the
most predominant contributor noted in the ATS clinical descrip-
tors. Hypo-perfusion is well discussed in the literature but more
broadly than severe sepsis including trauma.20–24 Howell et al20
reported that serum lactate was a stronger predictor of mortality
and hypo-perfusion than hypotension and tachycardia in the
ED. This was also evident in the study by Salottolo et al,21 in
which venous lactate was a stronger predictor of mortality com-
pared with the Shock Index (hypotension and tachycardia) espe-
cially in the elderly patients. Also, the 2012 sepsis guidelines
‘suggest targeting resuscitation to normalize lactate in patients
with elevated lactate levels as a marker of tissue hypo-perfusion
(grade 2C).’6 In this study, the ‘circulatory compromise’ variable
contained quite broad haemodynamic and perfusion criteria and
had a stronger association with mortality than elevated lactate.
Nevertheless, the measurement of venous serum lactate as a
point of care test, especially in the elderly patient whose signs
and symptoms often do not reﬂect hypo-perfusion,21 22 would
be a beneﬁcial and time efﬁcient addition to the triage process.
Limitations
This study has several limitations. First, as this was a predeter-
mined cohort of severe sepsis patients, the false rate of identiﬁ-
cation was not pragmatic for the ATS overall and could only be
analysed in the ATS categories. We could only report the sensi-
tivity; its effect on speciﬁcity was unknown and needs further
investigation.
Second, the identiﬁcation of severe sepsis relied on documen-
ted keywords and physiological vital sign data in the patient’s
triage notes. The urgency for resuscitation will always remain a
priority to documentation; hence, the need to move urgent
patient cases to a priority care may have preceded the process of
documentation. Despite the careful process employed to deter-
mine the identiﬁed classiﬁcation, in reality, there may have been
a higher rate of identiﬁcation than reported. Unavoidably, given
the time spent in the ED, the patient may have deteriorated to a
severe sepsis state between triage and admission to the ICU,
further reducing the proportion of numbers classiﬁed as identi-
ﬁed. Regardless of these issues, this was a ﬁve site study with a
Table 5 Univariate and multivariate predictors of hospital mortality
Variable
Univariate
95% CI p Value
Multivariate
95% CI p ValueOR OR*
Total cohort 1.00†
Temperature Fever >38°C 0.997 0.849 to 1.48 0.414 – – –
Temperature <36°C 1.24 0.896 to 1.73 0.190 – – –
RR ≥30 1.79 1.34 to 2.38 <0.001 1.43 1.28 to 2.27 <0.001
Nausea/vomiting 1.74 0.566 to 0.963 0.026 – – –
Lactate>4 mmol/L 1.80 1.77 to 3.00 <0.001 1.63 1.10 to 2.89 <0.001
Circulatory compromise 2.01 1.51 to 2.70 <0.001 1.78 1.34 to 2.75 <0.001
Severe sepsis identified at triage 0.812 0.697 to 0.946 0.007 0.891 0.776 to 947 <0.007
Not identified at triage 1.20 1.05 to 1.43 0.007 –
ATS 1 1.71 1.21 to 2.41 0.002 1.55 1.09 to 2.35 <0.005
ATS 2 1.04 0.804 to 1.35 0.061 – – –
ATS 3 0.142 0.103 to 0.194 <0.001 0.167 0.118 to 0.245 <0.001
ATS 4 0.084 0.061 to 0.115 <0.001 0.088 0.060 to 0.118 <0.001
Appropriate antimicrobial administration‡ 0.838 0.434 to 1.72 0.086 –
No deaths registered for ATS category 5—omitted.
LR χ2 (8 df)=219.92, p<0.000, Hosmer–Lemeshow, p=0.297. C statistic=0.776.
*Backwards stepwise multivariate logistic regression adjusted for age, SOFA score, APACHE II score and shock.
†Reference value hospital mortality 29%.
‡In the emergency department.
ATS, Australasian Triage Scale at emergency department Triage; LR, Likelihood ratio.
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signiﬁcant cohort and time frame and gave considerable scope
to analyse the ATS and its categories as a tool for the identiﬁca-
tion and early management of the deteriorating severe sepsis
patient.
Summary
Overall, the ATS was a valid and moderately accurate tool to
identify severe sepsis patients especially in the ATS 2–4 categor-
ies. Despite this, clinical efﬁcacy and safety were limited with
only 53% of cases classiﬁed as identiﬁed and only 40% receiv-
ing antimicrobial therapy within the SSCG timeframes.
Hypo-perfusion may have been inadvertently the variable identi-
ﬁed as it is a predominate feature of severe sepsis. The triage
process would beneﬁt from the addition and elevation of more
infection related and severe sepsis descriptors to the ATS and
the point of care testing of lactate as a discriminator in sus-
pected patients with severe sepsis.
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